Tag: Liver Disease: Misc.
Dapagliflozin Beneficial for Improving MASH Without Worsening Fibrosis
Dapagliflozin results in more patients with improved or resolved MASH without worsening of fibrosis, improved fibrosis without worsening of MASH
Residual Inflammation Seen in One-Third of Patients With Psoriasis on Biologics
Residual inflammation significantly linked to higher BMI, metabolic dysfunction-associated steatotic liver disease, baseline systemic inflammation
Metabolic Dysfunction-Linked Steatotic Liver Disease Tied to Increased Preterm Birth Risk
No increased risk seen for congenital malformation, stillbirth, or neonatal death
Simultaneous Liver Transplant, Sleeve Gastrectomy Beneficial
Results showed durable weight loss, resolution of diabetes and hypertension, and reduction in allograft steatosis
Study IDs Trends in 2015 to 2023 Mortality for Chronic Liver Disease
Increasing trend in metabolic dysfunction-associated steatotic liver disease-related mortality steeper than that for alcohol-related liver disease mortality
DDW: Certain Proteins Predict Metabolic Dysfunction-Associated Steatotic Liver Disease
Significant deviations seen in plasma concentrations of five proteins up to 16 years before onset of MASLD
Statins May Reduce Risk for Hepatocellular Carcinoma in Chronic Liver Disease
Improved Fibrosis-4 group transitions seen over time for patients with chronic liver disease using statins
Gastrointestinal Complications From Alcohol Increasing in Young People
Findings seen particularly for acute pancreatitis
Guidance Provided for PCPs to Identify Biliary Atresia in Newborns by 2 to 4...
Three-step strategy composed of examination of infant eye color, stool color, and prior laboratory results
Metabolic Surgery May Be Beneficial in MASH-Related Cirrhosis, Obesity
Significantly lower 15-year cumulative incidence of major adverse liver outcomes seen in those undergoing metabolic surgery
